- Home
- ZDGE vs CYCC Comparison
ZDGE vs CYCC Comparison
Compare ZDGE & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- CYCC
- Stock Information
- Founded
- ZDGE 2008
- CYCC 1992
- Country
- ZDGE United States
- CYCC Malaysia
- Employees
- ZDGE N/A
- CYCC N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- CYCC Health Care
- Exchange
- ZDGE Nasdaq
- CYCC Nasdaq
- Market Cap
- ZDGE 40.3M
- CYCC 47.6M
- IPO Year
- ZDGE N/A
- CYCC N/A
- Fundamental
- Price
- ZDGE $2.15
- CYCC $0.23
- Analyst Decision
- ZDGE
- CYCC Strong Buy
- Analyst Count
- ZDGE 0
- CYCC 1
- Target Price
- ZDGE N/A
- CYCC $11.00
- AVG Volume (30 Days)
- ZDGE 40.2K
- CYCC 162.6K
- Earning Date
- ZDGE 06-09-2025
- CYCC 05-13-2025
- Dividend Yield
- ZDGE N/A
- CYCC N/A
- EPS Growth
- ZDGE N/A
- CYCC N/A
- EPS
- ZDGE N/A
- CYCC N/A
- Revenue
- ZDGE $29,412,000.00
- CYCC $43,000.00
- Revenue This Year
- ZDGE $0.34
- CYCC $137.21
- Revenue Next Year
- ZDGE $6.35
- CYCC N/A
- P/E Ratio
- ZDGE N/A
- CYCC N/A
- Revenue Growth
- ZDGE 4.26
- CYCC N/A
- 52 Week Low
- ZDGE $1.73
- CYCC $0.17
- 52 Week High
- ZDGE $4.38
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- ZDGE 49.76
- CYCC 43.58
- Support Level
- ZDGE $1.97
- CYCC $0.17
- Resistance Level
- ZDGE $2.26
- CYCC $0.32
- Average True Range (ATR)
- ZDGE 0.19
- CYCC 0.02
- MACD
- ZDGE 0.02
- CYCC 0.00
- Stochastic Oscillator
- ZDGE 65.98
- CYCC 75.25
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.